India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Redfin forecasts a slow but meaningful return to normalcy in the U.S. housing market starting in 2026. Instead of a crash or a rapid correction, the year marks the beginning of a “Great Housing Reset” where affordability gradually improves, mortgage rates ease into the low‑6% range, home sales tick upward, and renters, buyers, and professionals finally feel less market pressure. From wage growth outpacing home prices to rising refi activity and the rise of AI‑powered real estate tools, 2026 is shaping up to be a foundational year for real estate careers and long‑term market stability.
Hurricane Melissa’s destruction in Jamaica highlights a growing global reality: climate risks are accelerating faster than insurance adoption. With more than 90% of disaster losses in developing regions going uninsured and a worldwide protection gap exceeding $1.8 trillion annually, experts warn that traditional insurance systems can no longer keep up. New models—like parametric payouts, community‑based aggregation and bundled climate tools—are emerging, but governments and corporations must step in to prevent financial shocks from destabilizing entire economies.
Gravis Robotics, a Zurich-based startup, just raised $23 million to bring autonomous tech to construction sites facing a massive operator shortage. As demand surges for renewable energy projects, data centers, and new housing, Gravis retrofits traditional heavy machinery with AI-driven systems that can work autonomously or via remote guidance. With trials already underway across seven countries, the company is pushing a future where humans and robots collaborate — speeding up development timelines and reshaping industries from construction to real estate.
Zillow has quietly removed its climate‑risk scores after months of pressure from agents, homeowners, and listing services who said the warnings were scaring off buyers. The move has sparked a national debate: Is this a win for real estate sales or a setback for consumer transparency? Critics warn that without clear climate‑risk data, families could be “flying blind” into costly surprises like insurance spikes and flood damage. As climate impacts intensify and disclosure expectations rise, real estate professionals must stay informed—because whether Zillow shows the data or not, the risks aren’t going anywhere.
Florida’s property insurance crisis is becoming the defining issue heading into the 2026 election season. Republicans argue that recent reforms are finally stabilizing the market, pointing to reduced litigation and cooling reinsurance costs. Democrats counter that families are still facing unbearable premiums, with condo prices dropping over 8% and Floridians paying some of the highest insurance rates in the nation. As lawmakers prepare to return to Tallahassee, the future of insurance reform is set to become the central political fight—one that will directly impact homeowners, investors, and real estate professionals across the state.
Connectivity has become one of the most powerful differentiators in today’s real estate market. As smart buildings, automation, and sustainability demands accelerate, fiber networks are replacing outdated copper systems and reshaping property value. With lower energy use, unified smart‑building capabilities, reduced long‑term costs, and stronger tenant satisfaction, digital infrastructure is now central to investment strategy. Real estate professionals who understand this shift gain a competitive edge as the industry moves toward cleaner, smarter, more connected buildings.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
